News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kaufmann Hitto
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/28/2023 |
4
| Kaufmann Hitto (Chief Scientific Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 249,080 options to buy
@ $1.39, valued at
$346.2k
|
|
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2021 |
4
| Kaufmann Hitto (SVP, Chief Scientific Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 220,000 options to buy
@ $2.5, valued at
$550k
|
|
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2019 |
4
| Kaufmann Hitto (SVP, Chief Scientific Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 300,000 options to buy
@ $4.65, valued at
$1.4M
|
|
| 09/03/2019 |
3
| Kaufmann Hitto (SVP, Chief Scientific Officer) has filed a Form 3 on PIERIS PHARMACEUTICALS, INC. |
|
|